- 55
- 20 574
VALIDATE Network
เข้าร่วมเมื่อ 19 ต.ค. 2018
VALIDATE is an international network of researchers working together to accelerate the development of vaccines against tuberculosis (TB), leishmaniasis, melioidosis & leprosy. It is led by the University of Oxford and funded by the UK's Medical Research Council and the Bill & Melinda Gates Foundation. We also aim to facilitate the career progression of our members. Find out more at www.validate-network.org.
VALIDATE Pump Priming explained
Join Dr Suereta Fortuin for an informative session on the upcoming VALIDATE Pump-Priming Grants - Round 6. This event is designed for VALIDATE Network members who are interested in applying for funding to support vaccine development research on diseases such as Leishmaniasis, Melioidosis, Leprosy, and Tuberculosis.
The session will cover:
An Overview of the Pump-Priming Grants
Advice and tips for preparing a competitive application
Important deadlines and submission details
Q&A session to address your specific questions
This session especially benefits Early Career Researchers and those seeking collaborative opportunities to secure funding for innovative projects. Don't miss this chance to get expert advice on navigating the application process and making the most of this funding opportunity.
Please complete the registration form below to secure your spot at the event.
The session will cover:
An Overview of the Pump-Priming Grants
Advice and tips for preparing a competitive application
Important deadlines and submission details
Q&A session to address your specific questions
This session especially benefits Early Career Researchers and those seeking collaborative opportunities to secure funding for innovative projects. Don't miss this chance to get expert advice on navigating the application process and making the most of this funding opportunity.
Please complete the registration form below to secure your spot at the event.
มุมมอง: 69
วีดีโอ
VALIDATE Seminar: Immunopathogenesis in cutaneous leishmaniasis
มุมมอง 1554 หลายเดือนก่อน
Cutaneous leishmaniasis caused by Leishmania parasites exhibits a wide range of clinical manifestations. Although parasites influence disease severity, cytolytic CD8 T cell responses mediate disease. While these responses originate in the lymph node, we find that expression of the cytolytic effector molecule granzyme B is restricted to lesional CD8 T cells in Leishmania-infected mice, suggestin...
VALIDATE Seminar: BCG & COVID - A century-old vaccine in a novel proposal for heterologous recall d
มุมมอง 824 หลายเดือนก่อน
Recently, there have been strong indications that it is possible to increase the immune response by a second dose of BCG vaccine. Thus, the BCG vaccine re-emerged to be considered based on a significant protective effect of BCG revaccination against TB and supporting its beneficial non-specific, agnostic, or heterologous effects. The latter has also been reported to reduce neonatal sepsis, resp...
VALIDATE ECDN Explained
มุมมอง 455 หลายเดือนก่อน
The Early Career Development Network (ECDN) provides tailored support and resources for post-doctoral and early PI researchers who identify as female or non-binary, fostering professional growth and addressing career challenges within the VALIDATE community. A call for cohort 2 is currently open, so on 1 May, VALIDATE Network Executive Manager, Samantha Vermaak, will host an online session wher...
VALIDATE Seminar Developing vaccines in a developing country
มุมมอง 566 หลายเดือนก่อน
The recent COVID-19 pandemic made it clear that a lot could be gained from decentralised vaccine development. Also, many diseases are localized to Low and Middle Income Countries, especially in tropical regions. However, research in immunobiologicals is costly and requires infrastructure and collaborations that are scarce in poorer countries. In this seminar Breno Beirão exploree two important ...
Developing novel 'point of need' molecular tools for monitoring treatment efficacy in Skin NTDs
มุมมอง 627 หลายเดือนก่อน
In 2022, VALIDATE initiated the project: “Develop novel test for PKDL/Leprosy diagnosis”. This project, led by Prof Chatterjee, aims to address the challenge of post-kala-azar dermal leishmaniasis (PKDL) in South-East Asia. PKDL cases can harbor parasites, perpetuating the transmission cycle of the disease. The team plans to develop a field-applicable diagnostic tool, building on a validated is...
VALIDATE Fellowship - Q&A with Sam Vermaak
มุมมอง 1338 หลายเดือนก่อน
Please note that the fellowship call closes on 8 April 2024 This seminar took place on 17 January 2024 and provided VALIDATE members with a chance to hear more information about the VALIDATE Fellowship grant call, hear some tips and advice, and hear from current VALIDATE Fellows about their experiences. VALIDATE members to ask any questions you may have to VALIDATE Executive Manager Samantha Ve...
VALIDATE One Health Seminar Three: Cross-species Disease Transmission and Mitigation Strategies
มุมมอง 449 หลายเดือนก่อน
In September 2023, members of the VALIDATE network and subject matter experts from around the world convened in Paarl, South Africa, to explore the application of the One Health model in the development of vaccines for Tuberculosis (TB) and Leishmaniasis. The One Health model is an interdisciplinary approach that acknowledges the interrelationships between human health, animal health, and envir...
VALIDATE One Health Seminar Two: Health System and Infrastructure Challenges in One Health
มุมมอง 2710 หลายเดือนก่อน
In September 2023, members of the VALIDATE network and subject matter experts from around the world convened in Paarl, South Africa, to explore the application of the One Health model in the development of vaccines for Tuberculosis (TB) and Leishmaniasis. The One Health model is an interdisciplinary approach that acknowledges the interrelationships between human health, animal health, and envir...
One Health Seminar: Inequitable Access to Medicines and Health Technologies in a One Health Context
มุมมอง 15910 หลายเดือนก่อน
In September 2023, members of the VALIDATE network and subject matter experts from around the world convened in Paarl, South Africa, to explore the application of the One Health model in the development of vaccines for Tuberculosis (TB) and Leishmaniasis. The One Health model is an interdisciplinary approach that acknowledges the interrelationships between human health, animal health, and envir...
How have you found the ECR Workshop?
มุมมอง 28ปีที่แล้ว
Following the very successful "Storytelling for Scientists" workshop, VALIDATE once again asked First Create The Media to provide their members with an in-person, full-day interactive workshop that helped build skills and confidence to talk about their research to the audiences that mattered. The workshop covered: - How to construct a compelling story and create a toolkit to communicate researc...
The VALIDATE 5th Annual Meeting 2023
มุมมอง 48ปีที่แล้ว
The 5th VALIDATE Annual Meeting was held on 7-8 March 2023 at the historic BMA House in London, UK. As always, our Annual Meeting gave our members talks from world-leading scientists in our research field, updates from our funded projects on their cutting-edge research, and the chance to meet members from across the globe. 2023 was the first in-person VALIDATE event since 2019, and it was a ple...
How is VALIDATE supporting Early Career Researchers and their career development?
มุมมอง 27ปีที่แล้ว
VALIDATE members discuss the support we offer to Early Career Researchers.
What is VALIDATE and what are some of its successes?
มุมมอง 28ปีที่แล้ว
VALIDATE members discuss the network and its impact on vaccine development for tuberculosis, melioidosis, leishmaniasis, and leprosy
How have you found the VALIDATE Annual Meeting 2023 and would you recommend it?
มุมมอง 13ปีที่แล้ว
VALIDATE members discuss the Annual Meeting 2023, which took place at BMA House, London 7 - 8 March 2023. www.validate-network.org/annual-meeting-2023
What are the benefits to members of being part of VALIDATE?
มุมมอง 71ปีที่แล้ว
What are the benefits to members of being part of VALIDATE?
How is VALIDATE working to accelerate vaccine development?
มุมมอง 20ปีที่แล้ว
How is VALIDATE working to accelerate vaccine development?
VALIDATE Seminar Spore FP1 mucosal vaccine candidate for TB
มุมมอง 138ปีที่แล้ว
VALIDATE Seminar Spore FP1 mucosal vaccine candidate for TB
VALIDATE Seminar Development of recombinant BCG Vaccine for tuberculosis utilizing Major Membrane
มุมมอง 92ปีที่แล้ว
VALIDATE Seminar Development of recombinant BCG Vaccine for tuberculosis utilizing Major Membrane
Vaccine against Human Leishmaniasis: Institut Pasteur de Tunis Contribution with Prof Dhafer Laouini
มุมมอง 73ปีที่แล้ว
Vaccine against Human Leishmaniasis: Institut Pasteur de Tunis Contribution with Prof Dhafer Laouini
Targeting FOXO3 transcription factor as a Host-Directed approach to enhance the efficacy of BCG
มุมมอง 76ปีที่แล้ว
Targeting FOXO3 transcription factor as a Host-Directed approach to enhance the efficacy of BCG
Targeting Immunometabolism in Host Defense Against Mycobacterium Tuberculosis
มุมมอง 193ปีที่แล้ว
Targeting Immunometabolism in Host Defense Against Mycobacterium Tuberculosis
A Vaccine for Leprosy? A VALIDATE Seminar
มุมมอง 3482 ปีที่แล้ว
A Vaccine for Leprosy? A VALIDATE Seminar
VALIDATE Seminar - A Vaccine for Leishmaniasis
มุมมอง 2862 ปีที่แล้ว
VALIDATE Seminar - A Vaccine for Leishmaniasis
A few things you might not know about Leishmaniasis
มุมมอง 5302 ปีที่แล้ว
A few things you might not know about Leishmaniasis
BCG Adventures - Three educational games for kids...all about vaccines!
มุมมอง 142 ปีที่แล้ว
BCG Adventures - Three educational games for kids...all about vaccines!
Tuberculosis infection and T cell mediated immunity
มุมมอง 6103 ปีที่แล้ว
Tuberculosis infection and T cell mediated immunity
TB and the use of BCG in Animals Does it matter to people
มุมมอง 2283 ปีที่แล้ว
TB and the use of BCG in Animals Does it matter to people
Thenk you 👍
B
cannot hear you!!
Kaha milega ye injection
Saan po ba nakakabili ng gamut n ito
Saan po ba nakakabili ng gamut n ito
Meron po bang gamut n habibi at Saan ito
Deo4
Sir ye veksin kha milti hai
Thank you very much sir . Good Luck !!!👍😊😀😀😀😀
oh wait look ....another vaccine.. o joy